Are Endovascular Interventions for Central Vein Obstructions Due to Cardiac Implanted Electronic Devices Effective?

Overview

Journal Front Surg

Specialty General Surgery

Date 2018 Aug 15

PMID 30105227

Citations 2

Authors

Charalampos Sotiriadis

Stephanie Volpi

Pauline Douek

Amine Chouiter

Olivier Muller

Salah D Qanadli

Affiliations

Soon will be listed here.

Abstract

One of the late-onset complications of cardiac implanted electronic devices (CIEDs) is central venous obstruction (CVO). The aim of this study was to investigate the feasibility, efficacy, and safety of endovascular treatment of CIED-related CVOs. Eighteen patients who underwent endovascular management of their device-related CVO were reviewed. Patients were classified into three groups: Group I patients were asymptomatic and needed lead replacement; Group II patients presented with symptomatic CVO without lead dysfunction, and Group III patients were referred with both symptomatic CVO and lead dysfunction. A treatment strategy involved recanalization and balloon angioplasty for Group I and angioplasty/stents for Groups II and III. Technical success, clinical success, complications, and long-term follow-up were assessed. Thirteen patients were in Group I, four in Group II, and one in Group III. Technical and clinical success was achieved in 17 patients (94%). No major complications were reported. Restenosis was observed in two patients at 40 and 42 weeks of follow-up, and these patients were successfully treated with angioplasty. Endovascular management of CVO due to CIED is a safe and efficient technique. Plain balloon angioplasty is sufficient for lead replacement purposes, while stenting is needed for symptomatic CVO to achieve good long-term patency.

Citing Articles

Balloon venoplasty for disdialysis syndrome due to pacemaker-related superior vena cava syndrome with chylothorax post-bacteraemia: A case report.

Yamamoto S, Kamezaki M, Ooka J, Mazaki T, Shimoda Y, Nishihara T World J Clin Cases. 2023; 11(35):8364-8371.

PMID: 38130610 PMC: 10731190. DOI: 10.12998/wjcc.v11.i35.8364.

Narrow Escape: A Novel Approach to the Endovascular Treatment of Superior Vena Cava Syndrome Secondary to Pacemaker Leads with Excellent Long-term Outcomes.

Malyshev Y, Ayzenberg S, Sahni S, Khalid M, Le J Cureus. 2020; 12(3):e7249.

PMID: 32292664 PMC: 7152578. DOI: 10.7759/cureus.7249.

References

Aryana A, Sobota K, Esterbrooks D, Gelbman A . Superior vena cava syndrome induced by endocardial defibrillator and pacemaker leads. Am J Cardiol. 2007; 99(12):1765-7. DOI: 10.1016/j.amjcard.2007.01.065. View

Spittell P, Hayes D . Venous complications after insertion of a transvenous pacemaker. Mayo Clin Proc. 1992; 67(3):258-65. DOI: 10.1016/s0025-6196(12)60103-7. View

Qanadli S, El Hajjam M, Mignon F, De Kerviler E, Rocha P, Barre O . Subacute and chronic benign superior vena cava obstructions: endovascular treatment with self-expanding metallic stents. AJR Am J Roentgenol. 1999; 173(1):159-64. DOI: 10.2214/ajr.173.1.10397119. View

Rozmus G, Daubert J, Huang D, Rosero S, Hall B, Francis C . Venous thrombosis and stenosis after implantation of pacemakers and defibrillators. J Interv Card Electrophysiol. 2005; 13(1):9-19. DOI: 10.1007/s10840-005-1140-1. View

Cantillon D, Dukkipati S, Ip J, Exner D, Niazi I, Banker R . Comparative study of acute and mid-term complications with leadless and transvenous cardiac pacemakers. Heart Rhythm. 2018; 15(7):1023-1030. DOI: 10.1016/j.hrthm.2018.04.022. View

Riahi L, Gabeler E, Prisecaru R, Schwagten B . A pacemaker lead implantation: what if we go through the stent strut cell?. Europace. 2016; 18(4):530. DOI: 10.1093/europace/euw058. View

Riley R, Petersen S, Ferguson J, Bashir Y . Managing superior vena cava syndrome as a complication of pacemaker implantation: a pooled analysis of clinical practice. Pacing Clin Electrophysiol. 2010; 33(4):420-5. DOI: 10.1111/j.1540-8159.2009.02613.x. View

Pecha S, Linder M, Gosau N, Castro L, Vogler J, Willems S . Lead extraction with high frequency laser sheaths: a single-centre experience. Eur J Cardiothorac Surg. 2017; 51(5):902-905. DOI: 10.1093/ejcts/ezw425. View

Li X, Ze F, Wang L, Li D, Duan J, Guo F . Prevalence of venous occlusion in patients referred for lead extraction: implications for tool selection. Europace. 2014; 16(12):1795-9. DOI: 10.1093/europace/euu124. View

10.

Maradey J, Jao G, Vachharajani T . Leadless pacemaker placement in a patient with chronic kidney disease: A strategy to preserve central veins. Hemodial Int. 2018; 22(4):E57-E59. DOI: 10.1111/hdi.12665. View

11.

Boczar K, Zabek A, Haberka K, Debski M, Rydlewska A, Musial R . Venous stenosis and occlusion in the presence of endocardial leads in patients referred for transvenous lead extraction. Acta Cardiol. 2017; 72(1):61-67. DOI: 10.1080/00015385.2017.1281545. View

12.

Safi M, Akbarzadeh M, Azinfar A, Namazi M, Khaheshi I . Upper extremity deep venous thrombosis and stenosis after implantation of pacemakers and defibrillators; A prospective study. Rom J Intern Med. 2017; 55(3):139-144. DOI: 10.1515/rjim-2017-0018. View

13.

Abu-El-Haija B, Bhave P, Campbell D, Mazur A, Hodgson-Zingman D, Cotarlan V . Venous Stenosis After Transvenous Lead Placement: A Study of Outcomes and Risk Factors in 212 Consecutive Patients. J Am Heart Assoc. 2015; 4(8):e001878. PMC: 4599456. DOI: 10.1161/JAHA.115.001878. View

14.

Cheng S . Superior vena cava syndrome: a contemporary review of a historic disease. Cardiol Rev. 2008; 17(1):16-23. DOI: 10.1097/CRD.0b013e318188033c. View

15.

Qanadli S, El Hajjam M, Bruckert F, Judet O, Barre O, Chagnon S . Helical CT phlebography of the superior vena cava: diagnosis and evaluation of venous obstruction. AJR Am J Roentgenol. 1999; 172(5):1327-33. DOI: 10.2214/ajr.172.5.10227511. View

16.

Worley S, Gohn D, Pulliam R . Excimer laser to open refractory subclavian occlusion in 12 consecutive patients. Heart Rhythm. 2010; 7(5):634-8. DOI: 10.1016/j.hrthm.2010.01.027. View

17.

Boczar K, Debski M, Zabek A, Haberka K, Slawuta A, Lelakowski J . Sex differences in venous stenosis and occlusion in patients with endocardial leads. Pol Merkur Lekarski. 2017; 42(251):187-192. View

18.

Melzer C, Lembcke A, Ziemer S, Eddicks S, Witte J, Baumann G . Pacemaker-induced superior vena cava syndrome: clinical evaluation of long-term follow-up. Pacing Clin Electrophysiol. 2007; 29(12):1346-51. DOI: 10.1111/j.1540-8159.2006.00546.x. View

19.

Breault S, Doenz F, Jouannic A, Dine Qanadli S . Percutaneous endovascular management of chronic superior vena cava syndrome of benign causes : long-term follow-up. Eur Radiol. 2016; 27(1):97-104. DOI: 10.1007/s00330-016-4354-y. View

20.

Shakya S, Matsui H, Fushimi K, Yasunaga H . In-hospital complications after implantation of cardiac implantable electronic devices: Analysis of a national inpatient database in Japan. J Cardiol. 2017; 70(5):405-410. DOI: 10.1016/j.jjcc.2017.02.013. View